ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: identified GLG1, a Golgi‐associated protein functioning as a selectin ligand, as a potential interaction partner of the Bcr‐Abl oncoprotein in chronic myeloid leukemia; its phosphorylation may influence disease progression by altering Golgi function and associated signalling pathways.